Home › Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal - FTC
 

Keywords :   


Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal - FTC

2014-11-26 21:55:46| Biotech - Topix.net

Switzerland's Novartis AG has agreed to sell its nicotine patch, Habitrol, in order to win U.S. antitrust approval for a consumer healthcare joint venture with Britain's GlaxoSmithKline , the U.S. Federal Trade Commission said on Wednesday. The deal is part of a three-way transaction unveiled in April, which includes GSK buying Novartis' vaccines business, Novartis purchasing GSK's cancer drugs, and the two groups tying up in consumer healthcare.

Tags: win deal selling patch

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
02.07Ecolab Launches 100% Plastic-Free Wipe for Healthcare Settings
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Chattanooga Area High School Students Graduate from BASFs TECH Academy
02.07Atlantic Tropical Weather Outlook
02.07Fayette Pipe Transforms Black Steel Pipe with FayetteGuard
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Public Advisory Number 16A
More »